Cerebrospinal fluid haemoglobin as a monitoring biomarker for secondary brain injury after aneurysmal subarachnoid haemorrhage: prospective international multicentre validation study (HeMoVal)

Journal of Neurology, Neurosurgery and Psychiatry · Published 2026-07-31 · DOI 10.1136/jnnp-2026-338810

Free full text

Authors (36)

Kevin Akeret, Raphael Matthias Buzzi, Thomas Gentinetta, Moritz Saxenhofer, David Kronthaler, Elisa Colombo, Alexandra Grob, Bart Thomson, Nina Schwendinger, Amr Abdulazim, Joshua Haegler, Gwendoline Canzanella, Vincens Kaelin, Linda Baettig, Lucas Moritz Wiggenhauser, Maria Wostrack, Carolin Albrecht, Matthias Gmeiner, Julia Shawarba, Daniel Couto, Sandra Wymann, Andreas Wassmer, Marlies Illi, Kathrin Bieri, Karl Rössler, Andreas Gruber, Bernhard Meyer, Constantin Roder, Isabel Charlotte Hostettler, Basil Erwin Grüter, Nima Etminan, Luca Regli, Emanuela Keller, Ulrike Held, Dominik J Schaer, Michael Hugelshofer

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Akeret, K., Buzzi, R., Gentinetta, T., et al. (2026). Cerebrospinal fluid haemoglobin as a monitoring biomarker for secondary brain injury after aneurysmal subarachnoid haemorrhage: prospective international multicentre validation study (HeMoVal). Journal of Neurology, Neurosurgery and Psychiatry. https://doi.org/10.1136/jnnp-2026-338810

Related articles